Nipro Corp
TSE:8086

Watchlist Manager
Nipro Corp Logo
Nipro Corp
TSE:8086
Watchlist
Price: 1 481.5 JPY -1.04% Market Closed
Market Cap: 241.6B JPY
Have any thoughts about
Nipro Corp?
Write Note

Nipro Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nipro Corp
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Nipro Corp
TSE:8086
Operating Income
ÂĄ22.3B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
4%
Hoya Corp
TSE:7741
Operating Income
ÂĄ227.9B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
9%
H
Hogy Medical Co Ltd
TSE:3593
Operating Income
ÂĄ3.9B
CAGR 3-Years
-13%
CAGR 5-Years
-3%
CAGR 10-Years
-8%
Shofu Inc
TSE:7979
Operating Income
ÂĄ5.5B
CAGR 3-Years
17%
CAGR 5-Years
17%
CAGR 10-Years
14%
Menicon Co Ltd
TSE:7780
Operating Income
ÂĄ9.2B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Mani Inc
TSE:7730
Operating Income
ÂĄ8.4B
CAGR 3-Years
16%
CAGR 5-Years
7%
CAGR 10-Years
8%
No Stocks Found

Nipro Corp
Glance View

Market Cap
241.6B JPY
Industry
Health Care

Nipro Corporation, a prominent player in the medical industry, began as a humble glass-tubing business in the heart of Japan in 1954. Over the decades, it metamorphosed into a sprawling conglomerate with a nuanced focus on healthcare. Today, Nipro is intricately woven into the fabric of the medical supply chain. Its products range from dialysis equipment to diabetes care and even medical glass products, evidencing a broad spectrum of specialties. This diversification is not simply an expansion but a strategic integration that enables the company to leverage its expertise across related domains, ensuring resilience in the ever-evolving healthcare market. The engine powering Nipro’s business model lies in its vertical integration and global footprint. By manufacturing an array of products internally, from raw materials like glass and plastics to final medical devices, Nipro maintains stringent quality control and cost efficiencies. Beyond Japan, the company has established a significant presence in over 50 countries, tapping into diverse markets with its extensive portfolio. Strategic partnerships and mergers further bolster its global expansiveness, enhancing its distribution networks. The seamless intersection of innovation, quality, and market reach solidifies Nipro's stature as a leading entity in healthcare solutions, driving its sustained financial performance.

Intrinsic Value
2 577.29 JPY
Undervaluation 43%
Intrinsic Value
Price

See Also

What is Nipro Corp's Operating Income?
Operating Income
22.3B JPY

Based on the financial report for Sep 30, 2024, Nipro Corp's Operating Income amounts to 22.3B JPY.

What is Nipro Corp's Operating Income growth rate?
Operating Income CAGR 10Y
4%

Over the last year, the Operating Income growth was -10%. The average annual Operating Income growth rates for Nipro Corp have been -5% over the past three years , -2% over the past five years , and 4% over the past ten years .

Back to Top